Biochemical evaluations of the effects of the sulfhydryl-containing angiotensin-converting Ž . enzyme inhibitor captopril on the nephrotoxicity induced by doxorubicin in normal rats Ž y1 . were carried out. A single dose of doxorubicin 15 mg kg which caused nephrotoxicity was manifested biochemically by the elevation of serum urea after 24 and 48 h of administration. Also a severe decrease in total proteins and albumin after 4, 24 and 48 h Ž . was observed. Moreover, a decrease of non-protein sulfhydryl ᎐SH concentrations in the kidney tissues after 24 h and an increase in the lipid peroxidation was observed after 4 h Ž y1
INTRODUCTION
Doxorubicin, an anthracyclin antibiotic represents a class of anticancer agents. It shows broad spectrum antitumour activities in certain human cancers including breast cancer, small cell carcinoma of the w x lung and acute leukaemia 1 . The optimal use of doxorubicin is limited by a number of side-effects, the most important are cardiotoxicity, haematotoxicw x w x ity 2᎐4 and a dose-limiting nephrotoxicity 5 . The exact mechanism of doxorubicin-induce nephrotoxicity is not yet known. However, it has been suggested by many investigators that cellular damage induced by doxorubicin is mediated by the formation of an w x iron anthracyclin free radical 6, 7 which in turn w x causes severe damage to the plasma membrane 8 .
Ž . Angiotensin-converting enzyme ACE activity U Corresponding author. plays a major role in arterial hypertension and nephrotoxicity and hence ACE inhibitors such as captopril are effectively used as antihypertensive w x agents 9 , and suggested to ameliorate nephrotoxicw x w x ity 10 . Recently, Al-Shabanah et al. 11 have reported that captopril ameliorates doxorubicin-induced cardio-and haematotoxicity in normal rats. The involvement of ACE inhibitors in amelioration of nephrotoxicity induced by doxorubicin is controversial and depends on the type and mode of action w x w x 12 . Some investigators 13, 14 reported that ACE inhibitors induced functional renal insufficiency, w x while others 15 declared that captopril partially inhibits the development of the functional and morphological damage induced by doxorubicin.
In view of the existing controversies on the role of Ž . ACE inhibitors captopril on the nephrotoxicity, it is worthwhile to gain further insight into the role of captopril as a free radical scavenger on the nephrotoxicity induced by doxorubicin.
MATERIALS AND METHODS

Chemicals
Captopril was obtained from Sigma Chemical Company, St Louis, MO, USA. Doxorubicin was purchased from Farmitalia, Carlo Erba, Milan, Italy. Drugs were dissolved in distilled water just before use.
Animals
Adult Albino rats of both sex, weighing 250᎐300 g, were obtained from the Experimental Animal Care Center of King Saud University, Riyadh, KSA. Animals were maintained under standard conditions of humidity with regular lightrdark cycles and free Ž . access to food Purina chow and water.
Experimental protocol
Eighty rats were divided into four groups, each consisting of 20 rats. The first, control group, received normal saline. 
Statistical analysis
Ž . Data are expressed as means " SEM . Statistical comparison between different groups were done by Ž . using one-way analysis of variance ANOVA followed by Tukey᎐Kramer multiple comparisons test. Significance was accepted at P-0.05.
RESULTS
Serum le¨el of urea and creatinine
Treatment with captopril failed to alter the serum urea and creatinine concentrations, however, doxorubicin administration significantly increased urea Ž . concentrations after 24 and 48 h P-0.05 whereas, creatinine concentrations tended to increase at 24 and 48 h compared to the values in the normal group.
The doxorubicin-induced increase in the renal function tests was reduced after treatment with captopril. Elevated concentrations of serum urea and creatinine were decreased after captopril administration, however, captopril failed to decrease the serum urea after 48 h. These changes were statistically significant as compared to the values obtained Ž . after treatment with doxorubicin alone Table I Total proteins and albumin
The plasma proteins and albumin were not af-Ž . fected after captopril treatment Table II , however, doxorubicin therapy was shown to decrease total proteins and albumin significantly after 4, 24 and 48 h as compared to the control values. Pretreatment with captopril significantly increased the total proteins and albumin concentrations after 4 and 24 h. However, the concentrations of plasma proteins are still significantly lower than the control after 24 and 48 h. Table III . A single i.p. injection of doxorubicin resulted in a decrease in the total non-Ž . protein sulfhydryl groups glutathione content in the kidney tissues after 24 h. Pretreatment with captopril did not increase the level of total non-protein sulfhydryl groups. There was no significant difference in the levels of tissue proteins among different groups.
Serum le¨els of calcium, sodium and potassium
There was no significant differences in the levels of calcium, sodium and potassium between different groups tested after captopril treatment. Also a single i.p. injection of doxorubicin did not induce any change in serum electrolyte levels.
DISCUSSION
Ž
In the present study, a single dose of doxorubicin 15 y 1 . mg kg induced nephrotoxicity manifested biochemically by a significant increase in serum urea and by a significant decrease in total proteins and albumin after 4, 24 and 48 h. Furthermore, our results are supported by a significant increase in malondialdehyde and a significant decrease in glutathione concentrations in the renal cells after treatment with doxorubicin. These results are consistent with previous studies reported by other investigators w x 5, 15, 22, 23 that doxorubicin induced nephrotoxic-Ž ity in normal rats. A single dose of captopril 60 mg y1 . kg given 1 h before doxorubicin, protected the kidney from damage induced by doxorubicin. This protection was clearly reflected by a decrease of serum creatinine, urea and by an increase in total proteins and albumin. Although captopril can not increase the glutathione content in the kidney tissues, it decreased lipid peroxidation induced by doxorubicin, thus captopril may protect kidneys by preventing lipid peroxidation.
The results of the present study that captopril did not elevate the glutathione content and decreases serum creatinine are not in agreement with the w x finding of Al-Harbi 24 who claimed that captopril decreases the glutathione level in the renal cells and did not decrease the higher creatinine concentrations after doxorubicin administration. However, captopril pre-treatment has been shown to be protective against nephrotoxicity induced by cisplatin. The basis of the controversies is due to the difference in the doses used and in the experimental design. Reduced glutathione was reported to protect the cells from cytotoxic damage induced by many w x compounds 25 and it is generally known as a potent w x factor in the control of lipid peroxidation 26 . Rew x cently Al-Shabanah et al. 11 declared that captopril ameliorates cardio-and haematotoxicity induced by doxorubicin.
Several proposals for the mechanisms of doxorubicin-induced nephrotoxicity have been put forward, involving the role of free radicals which are increasingly produced by doxorubicin. The findings of the present study that doxorubicin administration decreased the glutathione content in rat kidney after 24 h and increased lipid peroxidation after 4 and 24 w x h, are consistent with the previous report 27 that cisplatin administration to rats resulted in depletion of glutathione in the kidney cortical slices and that a relation exists between the cisplatin-induced nephrotoxicity and the depletion of glutathione conw x tent of kidney tissues 28 . It seems that lipid peroxidation is the main cause of doxorubicin-induced nephrotoxicity and that doxorubicin-induced lipid peroxidation is probably due to depletion of nonprotein sulfhydryl containing compounds.
Several natural and synthetic antioxidants have been implicated to minimise toxicity induced by free radical generation of doxorubicin, among them thy-Ž . moquinon TQ , a product derived from Nigella w x sati¨a seeds 29 . It has been reported that TQ inhibits membrane lipid peroxidation and eicosw x anoids generation by stimulated leucocytes 30 . The possibility that captopril protects the renal tissues against the doxorubicin-induced toxicity by scavenging the superoxide anion radicals is uncertain, since we recently reported that captopril at micromolar concentrations was not able to scavenge superoxide w x radicals in pure chemical systems 31 . However, an undergoing investigation in our laboratory shows that captopril totally abolished leukotriene B for- 4 mation from calcium ionophore-stimulated neutrophil. Leukotriene B is a highly superoxide anion 4 w x generator 32 . Therefore, it is possible that captopril may protect the renal tissues against doxorubicin-induced renal toxicity by indirectly inhibiting the generation of superoxide anion via inhibition of LTB 4 formation. w x Bolli et al. 33 reported that thiols can react with superoxide anion radicals, but the rate constant for these reactions is very low, usually -10 y3 M y1 s y1 . Therefore, other free radicals, such as hydroxyl radical and hypochlorous acid may be involved in mediating the toxicity of doxorubicin. Captopril has been Ž reported to react rapidly with hydroxyl radicals rate y3 y1 y1 . constant ) 10 M S and hypochlorous acid at w x micromolar concentrations 34 . Moreover, captopril was found to enhance the enzymatic activity of superoxide dismutase and selenium-dependent gluw x tathione-peroxidase 35 . Thus, the possible hydroxyl radical and hypochlorous acid scavenging ability, together with the interference of captopril with the binding of doxorubicin to DNA may explain at least in part, the observed protective effect of captopril against undesirable side-effects of doxorubicin.
In conclusion, lipid peroxidation and depletion of glutathione content are the main causes of doxorubicin-induced nephrotoxicity. Captopril which was useful for amelioration of cardio-and haematotoxicity induced by doxorubicin, can also protect the kidney against nephrotoxicity induced by doxorubicin. Further investigations are needed to explore the possible mechanism of the protective actions of captopril.
